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Abstract
Background: To support the early integration of palliative home care (PHC) in cancer treatment, we developed the
EPHECT intervention and pilot tested it with 30 advanced cancer patients in Belgium using a pre post design with
no control group. We aim to determine the feasibility, acceptability and perceived effectiveness of the EPHECT
intervention.
Methods: Interviews with patients (n = 16 of which 11 dyadic with family caregivers), oncologists and GPs (n = 11)
and a focus group with the PHC team. We further analyzed the study materials and logbooks of the PHC team
(n = 8). Preliminary effectiveness was assessed with questionnaires EORTC QLQ C-30, HADS and FAMCARE and were
filled in at baseline and 12, 18 and 24 weeks.
Results: In the interviews after the intervention period, patients reported feelings of safety and control and an
optimized quality of life. The PHC team could focus on more than symptom management because they were
introduced earlier in the trajectory of the patient. Telephone-based contact appeared to be insufficient to support
interprofessional collaboration. Furthermore, some family caregivers reported that the nurse of the PHC team was
focused little on them.
Conclusion: Nurses of PHC teams are able to deliver early palliative care to advanced cancer patients. However,
more attention needs to be given to family caregivers as caregiver and client. Furthermore, the home visits by the
PHC team have to be further evaluated and adapted. Lastly, professionals have to find a more efficient way to
discuss future care.
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Background
The World Health Organization (WHO) advises to pro-
vide palliative care early in the course of a life-
threatening illness – i.e. from diagnosis of advanced can-
cer on –, in conjunction with other therapies that are
intended to prolong life [1]. Similarly, the American So-
ciety of Clinical Oncology (ASCO) and the Multinational
Association of Supportive Care in Cancer (MASCC), the
European Society of Medical Oncology (ESMO) and the
European Association of Palliative Care (EAPC) in Eur-
ope also recommend palliative care to be introduced
early in the disease trajectory concurrent with active
treatment for advanced cancer patients with a life ex-
pectancy of 6 to 24 months [2].
Over the past few years, a growing number of studies
have investigated the effects of integrating palliative care
early in oncology care on the quality of life of patients
[3–10]. Most studies showed a positive effect, but all fo-
cused on integrating early palliative care in cancer treat-
ment in the hospital or in the outpatient setting. Up till
now, no studies have been published on integrating pal-
liative care early at home. Palliative care is indeed not
only provided in hospitals or via outpatient clinics but
also and especially at home. A recent systematic litera-
ture review shows that the majority of cancer patients
prefers to die in their own homes [11] and palliative
home care allows people to stay at home until death,
supported and surrounded by those close to them [12].
However, integrating palliative home care into standard
oncological treatment is more complex than early inte-
gration in hospital or outpatient clinics, as it requires in-
terprofessional and transmural collaboration – i.e.
collaboration between multidisciplinary teams at home
and in hospital. Hence, there is a need for an evidence-
based model for the early integration of palliative home
care in the current regular cancer treatment for ad-
vanced cancer patients that takes account of these
complexities.
To facilitate the early integration of palliative home
care in cancer treatment, we developed the Early Pallia-
tive Home Care Embedded in Cancer Treatment inter-
vention (hereinafter – EPHECT intervention) (Table 1)
[13]. Because the EPHECT intervention is one of the
first interventions worldwide focusing on the early inte-
gration of palliative home care in oncology care in the
hospital, it is important to first evaluate the feasibility,
acceptability and preliminary effectiveness of this inter-
vention in a phase 2 study before testing its effectiveness
in a large-scale phase 3 randomized controlled trial
(RCT). In this paper, we present the results of our
phase 2 study providing essential information about
the strengths and weaknesses of this specific interven-
tion, and insights about how an existing multidiscip-
linary service of palliative home care can be optimally
introduced and integrated early in a trajectory of ad-
vanced cancer.
Table 1 Overview of the components of the EPHECT intervention
Component Description
Education of involved professionals of the palliative home care
team
- Educational session of two hours for members of the PHC team consisting of
group discussions, case studies and education on drug therapies and side effects
- Training for the PHC team in working with the intervention materials
Information of involved oncologists - Involved oncologists are informed about the intervention and the role of the
PHC team
General practitioner (GP) as coordinator of care - GP were contacted by data nurse to give permission for introducing PHC to his/
her patient
- GP then contacted the PHC team to plan the first visit
- GP is the central coordinator of care and communicates with the PHC team and
oncologist
Regular home visits by the nurse of the palliative home care
(PHC) team
- In-person home visits with patient and family caregiver
- Recommendation of minimum one home visit per month, but to be discussed
with patient in first consultation
- Consultations supplemented with in-between telephone contacts if needed
Semi-structured home visits not only focusing on symptom
management, but also on psychological and social care
- Semi-structured conversation guide used in home visits of the PHC team in
which following topics are embedded:
o Understanding and perception of illness
o Routine symptom management (ESAS at each visit)
o Organization of care
o Coping mechanisms
o Quality of life of patient and family caregiver
o Preferences for future care
Interprofessional and transmural collaboration - Collaboration and communication via telephone contacts
- Patients discussed by the PHC team during weekly meetings
- GP should be contacted after each home visit and if needed after weekly
meeting
- If needed, GP should contact oncologist to discuss further actions
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The aims of this study are [1] to assess the feasibility
and acceptability of the study procedures (i.e. recruit-
ment, inclusion criteria) [2] to assess the feasibility and
acceptability of the components of the EPHECT inter-
vention, according to patients, family caregivers and
healthcare professionals; and [3] to explore preliminary
effectiveness and perceived effects of the EPHECT inter-




We designed a phase II pre-post trial following the guid-
ance of the Medical Research Council for the develop-
ment and evaluation of complex interventions [14, 15].
To assess feasibility and acceptability of the intervention
components, we conducted interviews with patients,
family caregivers, general practitioners (GPs) and oncol-
ogists and a focus group with the palliative home care
(PHC) team after the intervention. Patients and family
caregivers also had to fill in questionnaires at baseline
and at 12, 18 and 24 weeks follow-up to evaluate the
preliminary effectiveness of the intervention. Preliminary
effectiveness was assessed in order to evaluate the feasi-
bility and acceptability of the questionnaires used and to
select primary and secondary outcomes for a follow-up
Phase 3 RCT.
After oncologists screened patients for their eligibility
for the study (see Table 2 for inclusion criteria), the data
nurse introduced the EPHECT intervention to all eligible
patients and asked whether they were willing to partici-
pate. When patients agreed to participate and filled in
an informed consent, the data nurse contacted their GPs
because in Belgium the GP has to give permission to the
PHC team to start a trajectory with a patient. More de-
tails about the content and development of the EPHECT
intervention can be found in Table 1 and elsewhere [13].
Similar to previous models of early palliative care in
the hospital, the EPHECT intervention consists of regu-
lar visits of the palliative care team to the patient, in this
case at home, supported by a semi-structured conversa-
tion guide focusing on symptom management, psycho-
logical and social care. The EPHECT intervention also
incorporates a structured procedure by telephone con-
tact (see Table 1) for collaboration between the health
care settings, a component that is more complex and
elaborated compared with the other existing models as
integrating palliative home care requires collaboration
between settings of home (self-care and family care-
givers), primary care (GPs) and the hospital care (oncol-
ogists, oncology nurses, etc.).
We used the Consolidated Standards of Reporting Tri-
als (CONSORT) extension for Pilot and f-Feasibility Tri-
als Checklist as a methodological guidance for reporting
the EPHECT intervention [16].
Settings and participants
This study was performed in the home setting of ad-
vanced cancer patients in the Brussels region. We re-
cruited patients with advanced cancer from the Medical
Oncology departments of a university hospital and a
general hospital. All patients in treatment and all newly
diagnosed patients with a solid cancer diagnosis were
screened in the hospitals by the oncologists for their eli-
gibility (n = 41) (Table 2).
The Ethics Committees of the University Hospital and
of the regional hospital approved the study protocol. All
patients, informal caregivers and GPs involved in the
study provided their written informed consent.
Data collection
An overview of the methods to assess the feasibility, ac-
ceptability and preliminary effectiveness of the EPHECT
intervention can be found in Table 3.
– Feasibility and acceptability of the study procedures
was assessed by recording the number of all eligible
patients (and reasons for being not eligible), patients
who were asked to participate in the study, and
patients who agreed to participate (and reasons for
non-participation). We also recorded drop out dur-
ing the study (and reasons for drop out), and time of
death. Information about time of death was collected
from medical records and information about the
recruiting procedure was kept in the logbooks of the
researcher and the data manager.
Table 2 Inclusion and exclusion criteria
Inclusion Exclusion
- Non-curative treatable solid cancer diagnosis
- Life expectancy of 6 to 24months (assessed by treating
oncologist)
- Identification as having palliative needs (assessed by treating
oncologist)
- Active anticancer treatment
- 18 years or older
- Patients with the ability to read and respond to questions in
Dutch
- Hematological malignancy as primary diagnosis
- Not housed in the Brussels region
- No active anticancer treatment
- No permission of the GP
- More than one palliative care consultation with palliative team in hospital
before inclusion
- Involved in another palliative care intervention study
- Impaired cognition
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– Feasibility of the intervention was assessed
quantitatively, by registering the number and
duration of the visits done by the PHC team. The
content of the conversations and the estimated time
spent on the topics described in the semi-structured
conversation guide were collected by the nurses of
the PHC team in the electronic patient file. They
also registered the amount of and reasons for con-
tact of the PHC team with other professional care-
givers in the logbook for transmural collaboration.
Nurses of the PHC team were asked to keep a rec-
ord of contacts with GPs and oncologists in the care
for a patient. The contacts between GPs and oncolo-
gists were evaluated in the semi-structured inter-
views with GPs and oncologists.
– Acceptability of the intervention was assessed with
qualitative methods, i.e. semi-structured interviews
with patients (n = 16, of which 11 were dyadic inter-
views with a family caregiver), GPs and oncologists
(n = 11) involved in the intervention. Interviews with
patients, family caregivers and GPs focused on per-
ceived strengths, concerns and weaknesses of the
intervention and whether the intervention was ac-
ceptable. Interviews with oncologists focused on ex-
ploring strengths and weaknesses of the
intervention, and on their own role within the inter-
vention including their reflection on the inclusion
criteria. We also conducted a focus group with the
PHC team (n = 8) involved in the intervention, fo-
cusing on their experiences with the intervention
and the usability of the intervention materials.
– The preliminary effectiveness of the intervention was
assessed with questionnaires for patients and family
caregivers by comparing patient and caregiver
outcomes at baseline and after 12, 18 and 24 weeks.
The primary objective of the preliminary
effectiveness assessment was the patient’s quality of
life measured with the European Organisation for
Research and Treatment of Cancer Quality of Life
Questionnaire (EORTC QLQ C-30) [17]. Secondary
objectives were [1] the patient’s mood, assessed with
the Hospital Anxiety and Depression Scale (HADS)
[18] and illness understanding, measured by a ques-
tionnaire developed by Temel et al. [5] and trans-
lated by Vanbutsele et al. [19], [2] the informal
caregivers’ mood (HADS), satisfaction with care,
assessed with the Family Satisfaction with End-of-
Life Care (FAMCARE) [20] and illness understand-
ing. Those assessments were done to evaluate the
feasibility and acceptability of the questionnaires
used and to select primary and secondary outcomes
for a follow-up Phase 3 RCT.
– We also assessed perceived effectiveness of the
intervention in the interviews with patients, family
caregivers, GPs, oncologists and the focus group
with the PHC team.
Data analysis
Qualitative data A topic guide for the interviews and
the focus group, consisting of open questions and a set
of prompts, was developed by a member of the research




Logbooks researcher & data nurse
Electronic patient file
Inclusion procedure
Drop out & time of death
Questionnaires
• Missings





• Record of time spent on topics of the semi-structured guide in
electronic patient file
• Record of interprofessional contact in electronic patient file
Qualitative:
• Interviews with patients and family caregivers, GPs and oncologists
• Focus group with PHC team
Quantitative:
• Amount and content of visits




• Acceptability of the intervention components




• Questionnaires filled in by patients and family caregivers at
baseline and follow-up at 12, 18 and 24 weeks
Qualitative:
• Interviews with patients and family caregivers
Quantitative:
• Patient








• Patients’ and family caregivers’ perceived effects
of the EPHECT intervention
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team (ND) and reviewed within a multidisciplinary team
of researchers. Interviewers were a member of the re-
search team (ND) and a data manager (FS). The inter-
view guide consisted of questions regarding the
feasibility and acceptability of the intervention compo-
nents and the perceived effects of the intervention: 1)
What are your experiences with the intervention and the
intervention components?; 2) What are the barriers and
facilitators for implementing the intervention into clin-
ical practice?; 3) Did the intervention had effect on your
personal life (patients and family caregivers) or your pro-
fessional life (professional caregivers)?.
All interviews and the focus group were audio-
recorded, transcribed verbatim and analysed by a junior
and a senior researcher (ND and TS). Interviews were
analysed using thematic content analysis [21]. The data
analysis was both inductive and deductive. First, we
searched for preliminary codes on the basis of the
underlying structure of the interview. Second, those
codes were deductively linked to the intervention com-
ponents. The two researchers compared their codes and
when discrepancies occurred, consensus was sought
within the multidisciplinary research team.
Qualitative data analysis software (NVivo 11) was
used.
Quantitative data We included all data collected during
the study period. We calculated mean and standard de-
viations for each questionnaire at t0, t1, t2 and t3. The
mixed-effects linear model for repeated measures repre-
sents a proper statistical method to assess possible
changes in scores over time, allowing for differing num-
bers of measures per patient and accounting for missing
values, by incorporation of all available data into a single
model spanning the entire follow-up period. These char-
acteristics make this model ideal for investigating the
changes over time.
Results
Feasibility and acceptability of the study procedures
Inclusion & drop out of patients
From October 2017 to February 2018, all patients with
advanced cancer receiving active oncological treatment
in the two involved hospitals were screened for eligibility
by all oncologists. The EPHECT intervention was intro-
duced by the data manager to 41 eligible patients of
which 39 consented to participate and filled in a ques-
tionnaire at baseline. Of those 39 patients, 7 patients
died and 2 dropped out between baseline measurement
and the first visit of the PHC team four weeks later. The
2 patients who dropped out were not convinced of the
added value of the intervention. A flowchart of the study
can be found in Fig. 1.
Thus, 30 of the 41 eligible patients (73%) were visited
at least once by the PHC team. Characteristics of those
30 patients are presented in Table 4. The most common
cancer type was digestive cancer (47%), followed by lung
(17%) and Triple Negative breast cancer (17%). 26/30
patients (86,6%) filled in the questionnaire at 12 weeks,
21/30 (70%) at 18 weeks and 18/30 (60%) at 24 weeks.
Most of the patients who dropped out during the 24
weeks died, 2 patients dropped out due to personal
reasons.
Of those 30 patients, 13 included a family caregiver
who gave consent and also filled in a questionnaire at
baseline, 12, 18 and 24 weeks. Drop out in family care-
givers during the intervention period was directly linked
to drop out in patients.
Feasibility of inclusion and exclusion criteria
All 5 oncologists reported in the interviews that it was
easier to estimate a life expectancy of six months than
two years. Instead of using prognosis as primary inclu-
sion criterium, oncologists suggested to introduce pallia-
tive home care from diagnosis of an advanced disease.
Two made an exception for breast cancer because those
Fig. 1 Flowchart of the study
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patients could live for five or ten years with metastases.
They suggested to introduce palliative home care to those
patients after two episodes of chemotherapy. Some pa-
tients mentioned that they would have liked palliative
home care to be introduced even earlier in the disease tra-
jectory because it would have created more time and
space for building up a relationship with the PHC nurse.
Feasibility and acceptability of the intervention
components
To evaluate the feasibility and acceptability of the interven-
tion components, information from the logbooks of profes-
sional caregivers, conversation guides filled in by the PHC
team and electronic patient files were combined with infor-
mation gathered from the interviews with patients, family
caregivers and professional caregivers. Because the feasibil-
ity and acceptability of the intervention are closely linked,
we have decided to discuss each intervention component
separately with a combination of both the quantitative and
the qualitative data.
Only one GP was suspicious in the beginning about
the added value of visits by the PHC team for his pa-
tient. However, all GPs eventually gave permission to in-
clude their patients in the EPHECT intervention.
Education for nurses of the PHC team
Although nurses of the PHC team had the possibility to
ask questions about oncological diseases and treatments
in the information sessions, they had the feeling in the
first home visits that they did not know enough to an-
swer questions about oncology care. Instead of answer-
ing these questions, they empowered the patients in
asking the questions to the oncologist on the first fol-
lowing consultation. Despite nurses’ feelings of uncer-
tainty about their ability to handle issues related to
diagnoses, prognoses and oncological treatments at the
beginning of the intervention period, interviews with pa-
tients and family caregivers showed that the nurse of the
PHC team often provided information about diagnosis
and prognosis if needed and the nurses confirmed that
experience with early palliative care trajectories was im-
portant in increasing their self-efficacy.
Regular home visits by the PHC team
During the six-month intervention period, nurses of the
PHC team visited the patients on average four times. Six
patients were visited only once, five of them died before
the second visit and one patient found the visits too
time-consuming and not useful. Ten of 30 patients were
visited monthly as recommended in the intervention
protocol, resulting in six or more visits. Reasons that
members of the PHC team gave for visiting patients less
often or not monthly were that sometimes patients were
admitted to the hospital and visits had to be rescheduled
to a later time. Some visits to the patient’s home were
replaced by a telephone call when the patient did not
need a home visit for instance when they stabilized or
their condition improved. More frequent visits (more
often than once a month) occurred when the patient’s
health condition got worse or when the patient was
closer to death.
The 15 interviews with patients and family caregivers
showed that they did not have problems with being in-
volved in palliative home care whilst receiving ongoing
anticancer treatment and that visits were considered ne-
cessary monthly in the beginning of the trajectory for
building a trusting relationship. Most patients found that
once this relationship was established, monthly visits
were acceptable but not needed and most patients were
glad that the visits were planned by the PHC team. Some
patients told that they would not contact the PHC nurse
by themselves even though they evaluated the visits as
beneficial. The main reason for this lack of taking initia-
tive was that patients had other things to worry about









Home (cohabiting) 26 86,7%




Highest level of education
Lower than high school 3 10%
Lower level in high school 11 36,7%
Higher level in high school 10 33,3%
College, university 6 20%
Primary cancer diagnosis
Digestive 14 46,7%
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than contacting the PHC nurse. If their health condition
would stabilize or improve, some patients in that case
recommended to plan PHC visits according to their
needs. In the focus group the PHC team agreed for fu-
ture care on planning the visits in dialogue with the pa-
tient and the family caregiver, whilst following them up
by telephone.
Semi-structured conversation guide
Most nurses evaluated the conversation guide as a useful
tool to structure the conversations with the patient dur-
ing the home visits and to reflect back with the patient
and family caregiver on what was discussed during pre-
vious home visits. Few patients noticed that the visits
were always structured in the same way, but it did not
bother them.
Analyses of the patient files show that the main focus
of the visits was on physical symptom management.
Some patients reported that the nurse of the PHC team
had given them and the GP advise on medication use.
Analyses of the patient files also showed that being in-
volved earlier gave the nurses of the PHC team the op-
portunity to provide holistic care and to spend more
time on topics other than symptom management like
disease insight – reflecting on what the patient knows
about his/her disease, treatment and prognosis –, coping
with the illness and the treatments and advance care
planning. Members of the PHC team revealed in the
focus group that they were initially concerned that pro-
viding more holistic care would require a different ap-
proach and different skills, but the more experience they
gained with the intervention, the more they felt it was
their responsibility to discuss not only physical symp-
toms, but also preferences for future care, coping or
other psychosocial issues. According to patients and to
the nurses of the PHC team, psychosocial and existential
issues were indeed also important topics in the home
visits with the patient. One patient received support and
advise for sexual problems, others reported support on
financial and practical level. The PHC team also talked
with the patients about diagnoses and prognoses, infor-
mation that was often not given by the oncologist.
Lastly, analyses of the interviews showed that during
the home visits, little attention was given to how the
family caregiver was coping. Although most family care-
givers reported that they had received enough support of
the PHC team, some mentioned that the nurse of the
PHC team was mainly focused on the patient and that
they had expected to be involved more.
“I’d expected more from the support of that nurse.
The focus was still on my partner and I still had the
feeling that nobody listened to my concerns.” (family
caregiver)
Interprofessional and transmural collaboration with the GP
as coordinator of care
Analyses of the logbooks of the PHC team show that for
most patients, the GP was only contacted once by a
nurse of the PHC team, namely when palliative home
care was initiated, to let the GP know that the PHC
team was introduced to the patient. This contact was al-
ways by telephone. Only for a few patients the GP was
contacted more regularly, mostly when the patient dete-
riorated and was in the terminal phase of life or when
medication had to be adjusted. GPs therefore said that it
was difficult to take up their responsibility in being the
coordinator of the care trajectory. The PHC team rarely
contacted the oncologist directly because they did not
want to pass-by the GP.
Interviews with GPs and oncologists and the focus
group with the PHC team showed that PHC teams eval-
uated contact with the GP as unneeded when a patient
was stable, whilst GPs reported that they would have
liked to receive a short report after each visit from the
PHC team. The interviews also revealed that GPs as well
as nurses of the PHC team were sometimes difficult to
reach by telephone resulting in suboptimal interprofes-
sional communication and collaboration. Furthermore,
the majority of the GPs mentioned in the interviews that
they preferred being the communicator between the
PHC team and the oncologist, whilst all oncologists pre-
ferred to receive information directly from nurses of the
PHC team so that they could react immediately.
Based on the feasibility and acceptability of the inter-
vention components, we made suggested changes to the
EPHECT intervention which are shown in Table 5.
Preliminary effectiveness of the EPHECT intervention
Table 6 and Table 7 show results of preliminary effect-
iveness of the EPHECT intervention on quality of life,
mood and satisfaction with care. No significant deterior-
ation nor improvement over time was observed for any
questionnaire scales and subscales. Initial scores of fam-
ily caregivers on the anxiety scale were high and
remained high during the intervention.
Patients’ and family caregivers’ perceived effects of the
EPHECT intervention
Safe haven
The first visits of the PHC team were mainly used to
build up a relationship with the patient and the family
caregiver. Although the health condition of most pa-
tients was stable when the PHC team first visited them,
patients and family caregivers evaluated the visits as
positive. They reported in the interviews that having the
support of the PHC team whilst receiving chemotherapy
resulted in feelings of safety and trust. Especially family
caregivers felt safe because they knew who they could
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turn to when their beloved one’s condition would
deteriorate.
“You’re not alone anymore, it comforts me that I
know where I have to go to if I need someone or sup-
port.” (family caregiver)
Quality of life
Almost all patients reported that the EPHECT interven-
tion had a positive effect on their quality of life by inter-
ventions done or advised by the nurse of the PHC team
to relieve discomfort and to optimize their symptom
management.
Table 5 Suggested changes to the EPHECT intervention




- Educational session of two hours for
members of the PHC team
consisting of group discussions, case
studies and education on drug
therapies and side effects
- Training for the PHC team in
working with the intervention
materials
- Involved oncologists will be
informed about the intervention and
the role of the PHC team
- Training was too short to make
nurses of the PHC team comfortable
in having discussions on oncology
care
- Ongoing educational sessions or
possibilities to contact oncologists
if questions about oncology care
arise.
- Educational sessions should focus
more on involving the family
caregiver.
General practitioner (GP) as
coordinator of care
- GP will be contacted by data nurse
to give permission for introducing
PHC to his/her patient
- GP will then contact the PHC team
to plan the first visit
- GP is the central coordinator of care
and communicates with the PHC
team and oncologist
- GP was rarely contacted by the PHC
team, because the nurses of the PHC
team thought it was not needed to
contact the GP if the patient was
stable.
- GPs reported difficulties in taking up
the role of coordinator of care
because they were not involved
more than in standard care.
- Clear agreements have to be made
about how and when
communication has to take place,
in dialogue with the involved GPs,
PHC team and oncologists.
Regular home visits by the
palliative home care (PHC)
team
- In-person consultations with patient
and family caregiver
- Recommendation of minimum one
home visit per month, but to be
discussed with patient in first
consultation
- Consultations can be supplemented
with in-between telephone contacts
if needed
- Patients, family caregivers and nurses
of the PHC team said that it was
necessary to install monthly visits in
the beginning of the trajectory to
build up a relationship.
- Once the relationship is built,
monthly visits are not needed as
long as the situation is stable and
visits should be planned according
to the needs of the patients and
family caregivers.
- Monthly consultations at the
beginning of the trajectory.
- Later on: visits need to be planned
according to the needs of patients
and family caregivers.
- Regular follow-up by telephone on
initiative of the PHC team.
Semi-structured contacts not
only focusing on symptom
management, but also on
psychological and social care
- Semi-structured conversation guide
to be used in home visits of the PHC
team in which following topics are
embedded:
o Understanding and perception of
illness
o Routine symptom management
(ESAS at each visit)
o Organization of care
o Coping mechanisms
o Quality of life of patient and family
caregiver
o Preferences for future care
- Being involved earlier provided
nurses of the PHC team time to not
only focus on symptom
management, but also on other core
domains of palliative care as
recommended in the semi-
structured conversation guide.
- Coping of the family caregiver was
the topic least discussed and some
family caregivers reported in the
interviews that they had the feeling
during the intervention that the
nurse of the PHC team was mainly
focused on the patient.
- More attention needs to be given




- Collaboration and communication
via telephone contacts
- Patients will be discussed by the
PHC team during weekly meetings
- GP will be contacted after each
home visit and if needed after
weekly meeting
- If needed, GP will contact oncologist
to discuss further actions
- Telephone-based contact was
insufficient.
- GPs and nurses of the PHC team had
different opinions about when
contact was needed.
- GPs wanted to be the communicator
between the PHC team and the
oncologist, but were rarely
contacted. Oncologists reported to
prefer direct contact with the nurses
of the PHC team.
- Face-to-face contact between all
professional caregivers needs to be
installed to discuss future care.
- Clear agreements have to be made
about how and when
communication has to take place,
in dialogue with the involved GPs,
PHC team and oncologists.
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Communication between patient and family
Some patients and family caregivers felt that the nurse
facilitated conversations, especially when they were not
used to talk to their partner or family about their wor-
ries. One oncologist said in the interview that the EPHE
CT intervention was of great value for a patient and her
family because it brought the family together and facili-
tated communication about the dying process.
“This study really had an effect on that family. Be-
cause of your support, they have learned to commu-
nicate and they have grown more towards each
other.” (oncologist)
Empowerment and advance care planning
Some patients mentioned that the visits of the nurse of
the PHC team helped them in reflecting on their wishes
and needs and in discussing them with other profes-
sional caregivers. Two oncologists also reported that they
had the feeling that patients who participated in the EPHE
CT intervention became more assertive in stating their
wishes for future care and communicating their concerns
than they were before the start of the intervention.
Discussion
Main findings
This study shows that early integration of palliative
home care in oncology treatment is feasible and ac-
cepted for the most part by patients, family caregivers
and professional caregivers. Most of the participating pa-
tients, family caregivers and professional caregivers val-
ued the visits of the PHC team. Patients experienced
feelings of empowerment, safety and control and re-
ported to have received support to optimize their quality
of life. However, important challenges were found with
some of the intervention components that had an influ-
ence on the feasibility and acceptability of the interven-
tion. Telephone-based contact appeared to be
Table 6 Evolution of mean scores over time in quality of life and mood of patients with advanced cancer at baseline, 12, 18 and 24
weeks
Patients’ outcomes Range Assessment
Baseline (t0) 12 weeks (t1) 18 weeks (t2) 24 weeks (t3) P value
(N = 30) (N = 26) (N = 22) (N = 18)
Mean ± SD Mean ± SD Mean ± SD Mean ± SD
EORTC QLQ C-30
Global QOL 0–100 60,5 ± 16 58 ± 17,7 61,9 ± 17,6 62,5 ± 17,2 0,81
Physical functioning 0–100 60,9 ± 23,8 60,5 ± 23,2 60,9 ± 21,2 65,4 ± 23,1 0,90
Role functioning 0–100 59,4 ± 31,5 51,3 ± 29,6 53 ± 28 55,6 ± 32,8 0,78
Emotional functioning 0–100 69,6 ± 18,3 66 ± 24,6 67 ± 23,4 70,8 ± 24 0,88
Cognitive functioning 0–100 75 ± 23,1 68 ± 25,4 75 ± 25,1 69,4 ± 29,8 0,67
Social functioning 0–100 72,2 ± 23 73,1 ± 20,6 75,8 ± 19,1 69,4 ± 29,8 0,86
HADS
HADS – anxiety 0–21 7,9 ± 4,1 7 ± 4 6,2 ± 4,3 7,5 ± 5,1 0,55
HADS – depression 0–21 7,4 ± 3,6 7,3 ± 4,3 6,6 ± 3,7 7,1 ± 4,5 0,90
EORTC QLQ C-30: European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire (for all the EORTC QLQ C-30 scales the higher the
score, the better quality of life); HADS Hospital Anxiety and Depression Scale (for both HADS subscales the higher the score, the higher the distress)
Table 7 Evolution of mean scores over time in satisfaction with care and mood of family caregivers at baseline, 12, 18 and 24 weeks
Caregiver outcomes Range Assessment
Baseline (t0) 12 weeks (t1) 18 weeks (t2) 24 weeks (t3) P value
(N = 13) (N = 12) (N = 9) (N = 7)
Mean ± SD Mean ± SD Mean ± SD Mean ± SD
FAMCARE
Total score 0–100 70,7 ± 9,9 70,5 ± 13,7 70,6 ± 12,9 71,4 ± 17,5 0,99
HADS
HADS – anxiety 0–21 10,5 ± 4,5 10,5 ± 4,6 10,3 ± 3,7 11,3 ± 6,3 0,98
HADS – depression 0–21 8,5 ± 2,5 8,2 ± 4,4 6,6 ± 4,5 7,3 ± 5 0,73
FAMCARE: Family Satisfaction with End-of-Life Care (higher score means higher satisfaction with care); HADS: Hospital Anxiety and Depression Scale (for both
HADS subscales the higher the score, the higher the distress)
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insufficient to support collaboration between disciplines
and settings. Furthermore, the GP was not involved
more in the care trajectories than before the EPHECT
intervention and in most cases he or she had difficulties
with practicing the role of coordinator of care.
Discussion of the main findings
The majority of patients wants to be cared for and die at
home [11, 22]. Whilst previous studies focused on inte-
grating palliative care early in a hospital context, the
EPHECT intervention aims to introduce palliative care
early in the home context increasing the chances of
dying at home [23]. Another important added value
compared with some of the previous early palliative care
interventions [4, 9, 10] is that we performed a phase 2
study focusing on feasibility and acceptability of the
intervention components, taking into account the expe-
riences of patients, family caregivers as well as those of
professional caregivers involved in the intervention. Per-
forming a phase 2 study is more cost-effective than im-
mediately carrying out a large-scale phase 3 RCT
because now we can refine the intervention model based
on the experiences of the participants of the phase 2
study [14].
The drop-out of patients due to death during the
intervention period is striking given the inclusion crite-
rium of having an estimated life expectancy of 6 to 24
months. All participating oncologists reported that it was
possible to estimate a life expectancy of 6months, but they
found a life expectancy of 24months more difficult to pre-
dict. Previous research also shows that it can be difficult
for oncologists to estimate survival and that oncologists
might have the tendency to be overly optimistic [24–26].
Another possible explanation is that oncologists might
have deliberately included patients with a shorter life ex-
pectancy out of fear to deprive the hope of patients with a
longer estimated survival time, which has been reported as
a barrier for early integration of palliative home care in sev-
eral previous studies [27–33]. Future interventions on early
integrated palliative home care should have the discussion
of using needs-based or prognosis-based criteria to deter-
mine the eligibility of patients.
The protocol of the EPHECT intervention included
monthly consultations with a nurse of the palliative
home care (PHC) team. However, two thirds of the par-
ticipants received fewer consultations; the nurse of the
PHC team visited the patients on average four times in
the 6-month intervention period. According to patients
and family caregivers as well as according to the PHC
team, systematic visits are important at the beginning of
the trajectory because these visits allow to build a rela-
tionship of trust. Once the relationship is built, monthly
consultations are acceptable to patients but not necessary
as long as the patient’s situation is stable. In our
intervention protocol, we recommended to plan monthly
visits to patients based on previous interventions showing
a positive effect of systematic and early integration of pal-
liative care on patient-reported outcomes [3–5, 7, 9, 10,
34]. However, it remains unclear if continuing systematic
consultations at home is more effective than follow-up
consultations by telephone as used in the ENABLE inter-
ventions wherein structured telephone sessions were orga-
nized by a PC nurse [3, 4]. Future research is needed to
investigate the optimal frequency, structure and imple-
mentation of palliative care consultations to improve the
quality of life of patients with advanced cancer.
The home visits by the nurse of the PHC team were
mainly focused on symptom management and illness
understanding, but also psychosocial and existential is-
sues were addressed, which confirms findings of previ-
ous intervention studies on early palliative care [35–37].
As expected by the focus groups with PHC team in our
previous research [38], psychological issues are more
prominent earlier in the disease trajectory. At the begin-
ning of the intervention period the nurses of the PHC
team feared that they would not be able to manage these
issues because their previous experience was mainly fo-
cused on acute symptom management [38]. However,
their self-efficacy increased during the intervention. In
the information sessions for nurses of the PHC team we
did not focus on communication but to be prepared for
and feeling safe in having these conversations, we would
recommend to take this into account in future trainings
for palliative care teams.
This study also found that some family caregivers had
the feeling that the visits of the nurses of the PHC team
were mainly focused on the patient and that sometimes
little attention was given to how family caregivers were
coping with the disease of their beloved one. Further-
more, analyses of the HADS questionnaire for family
caregivers show that initial scores on anxiety were high
and remained high during the intervention period. Look-
ing at previous existing interventions, explicit advise and
guidelines on involving the family caregiver were rarely
made. In the EPHECT intervention coping of the family
caregiver was integrated in the semi-structured conver-
sation guide as a topic needed to be discussed. However,
analyses of the logbooks of the team confirm that this
topic was the least discussed one during the
conversations.
Family caregivers are often defined as unpaid, informal
providers of care who have a personal connection to the
patient and provide – especially when patients want to
be cared for at home – one or more physical, social,
practical and emotional tasks. By doing this, they are im-
portant actors in providing holistic palliative care [38].
However, taking up these tasks can cause anxiety and
other several needs that are often undertreated or not
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addressed [39–41]. Palliative care teams need to focus
more on supporting the family caregiver in caring for
their beloved one, as well as taking care of their own
needs.
Our intervention results shows that telephone-based
contacts mostly failed to improve interdisciplinary and
transmural collaboration. A recent influential Commis-
sion paper states that a multidisciplinary team approach,
with systematic collaboration among team members
from different professions within and across levels of
care, is needed to strive for optimized integrated pallia-
tive care [42]. A systematic review on interventions fo-
cusing on integration and oncology care reveals that of
the seven included only one advised to routinely involve
palliative care teams in multidisciplinary tumor confer-
ences and in only three of them communication and col-
laboration between the palliative and the oncological
service was established [43, 44]. There needs to be a shift
from coordinated care in which different teams are
linked but working in separate structures to integrated
care, in which professionals from different disciplines
and settings are gathered together to discuss future care
goals. To strive for optimized integrated care, the EPHE
CT intervention needs to be adapted on interprofes-
sional collaboration. Future trials need to consider using
interprofessional collaboration as an important outcome
to discuss the effectiveness of an intervention focused on
integrated palliative care.
Although we did not choose for a RCT design and
hence missed a control group to reflect on the trends in
scores on the EORTC QLQ C-30, HADS and FAMC
ARE, the lack of deterioration in the scores combined
with the subjective perceptions of patients and family
caregivers showed that the EPHECT intervention had
beneficial effects on different domains mentioned in the
definition of Heath Related Quality of Life (HRQoL),
leading to the assumption that the intervention in-
creased the quality of life of patients and family care-
givers. However, given the high scores on of family
caregivers on the anxiety subscale of the HADS, it will
be important in future interventions on early integrated
palliative home care to take into account the mood of
family caregivers as an important outcome to make as-
sumptions on the effectiveness of the intervention.
Strengths and limitations
Performing a phase 2 study is more cost-effective than
immediately carrying out a large-scale phase 3 RCT.
Based on the results of this phase 2 study necessary ad-
aptations can be made on the intervention model before
testing it in a trial with a larger study population. Fur-
thermore, conducting interviews with patients, family
caregivers and professional caregivers provided clear in-
sights on the feasibility and acceptability of the EPHECT
intervention. However, several limitations exist with
regards to the study design. First, by conducting a pre
post design, we had no control group. This makes it dif-
ficult to make assumptions about the trends seen in pa-
tient and family caregiver outcomes. Second, because of
the complex nature of the intervention, it is not possible
to make conclusions about the effectiveness of individual
components. We did not examine how the intervention
components were linked and which causal mechanisms
could lead to positive effects on certain outcomes. Com-
plementing the study with a more explicit theory-driven
approach and a thorough process evaluation could have
improved the design and evaluation of this complex
intervention [39].
Conclusion
This study shows that early integration of existing pallia-
tive home care in oncology treatment is feasible and ac-
cepted for the most part by patients, family caregivers
and professional caregivers. By making only small adjust-
ments to current practice, nurses of PHC teams are able
to deliver palliative care to advanced cancer patients be-
fore they are terminally ill. However, this phase 2 pre-
post study also provides essential information on how
the EPHECT intervention can be optimized before test-
ing its effectiveness in a large-scale phase 3 RCT. More
attention needs to be given to the support of the care
giving by family caregivers and to health care provision
of family caregivers. Furthermore, the optimal frequency
and structure of the home visits by the nurse of the
PHC team have to be further evaluated and adapted.
More challenging is the optimization of the integration
model. To strive for optimized integrated palliative care,
professional caregivers from different disciplines and set-
tings have to find a more efficient way to discuss com-
monly future care goals.
Abbreviations
PHC: Palliative home care; GP: General practitioner; WHO: World Health
Organization; RCT: Randomized controlled trial
Acknowledgements
Filip Schriers for co-conducting the interviews and the focus group.
All patients, family caregivers and professional caregivers who agreed to
be interviewed or to participate in a focus group.
Authors’ contributions
ND: conceptualization, data collection and curation, formal analysis,
investigation, methodology, writing – original draft. TS: conceptualization,
project administration, supervision, writing – review & editing. ADV:
conceptualization, writing – review & editing. LL: conceptualization, writing –
review & editing. KP: conceptualization, supervision, writing – review &
editing. LD: conceptualization, supervision, writing – review & editing. All
authors have read and approved the manuscript.
Funding
This work was supported by the Agency for Innovation by Science and
Technology (IWT) who funded the INTEGRATE-project of which my PhD was
one of the six studies [SBO-IWT 140009]. Annual progress reports were sent
to the funders to evaluate the progress of the papers and the PhD.
Dhollander et al. BMC Palliative Care          (2020) 19:174 Page 11 of 13
Availability of data and materials
The data of this study is kept by the first author and is available upon
request.
Ethics approval and consent to participate
The proposal for this study was submitted for approval to the commission of
medical ethics of the university hospital of Brussels (Commissie Medische
Ethiek UZ Brussel) with reference number B143201731750/I/U. All patients,





The Authors declare that there is no conflict of interest.
Author details
1End-of-life Care Research Group, Vrije Universiteit Brussel (VUB) & Ghent
University, Corneel Heymanslaan 10, 6K3, room 009, 9000 Brussels, Belgium.
2Department of Medical Oncology, Ghent University Hospital, Ghent,
Belgium. 3Cancer Research Institute Ghent (CRIG), Ghent University Hospital,
Ghent, Belgium. 4Department of Public Health and Primary Care, Ghent
University Hospital, Ghent, Belgium.
Received: 27 March 2020 Accepted: 19 October 2020
References
1. World Health Organization. WHO Definition of palliative care, http://www.
who.int/cancer/palliative/definition/en/ (2002).
2. Davis MP, Strasser F, Cherny N. How well is palliative care integrated into
cancer care? A MASCC, ESMO, and EAPC project. Support Care Cancer. 2015;
23:2677–85.
3. Bakitas M, Lyons KD, Hegel MT, et al. Effects of a palliative care intervention
on clinical outcomes in patients with advanced Cancer: the project ENABLE
II randomized controlled trial. JAMA. 2009;302:741–9.
4. Bakitas MA, Tosteson TD, Li Z, et al. Early versus delayed initiation of
concurrent palliative oncology care: patient outcomes in the ENABLE III
randomized controlled trial. J Clin Oncol. 2015;33(13):1438–45.
5. Temel J, Greer J, Muzikansky A, et al. Early palliative Care for Patients with
metastatic non–small-cell lung Cancer. N Engl J Med. 2010;363:733–42.
6. Tattersall MHN, Martin A, Devine R, et al. Early contact with palliative care
services: a randomized trial in patients with newly detected incurable
metastatic Cancer. Palliat Care & Med. 2014;4:1–6.
7. McCorkle R, Sangchoon J, Ercolano E, et al. An advanced practice nurse
coordinated multidisciplinary intervention for patients with late-stage
Cancer: a cluster randomized trial. J Palliat Med. 2015;18:962–9.
8. Zimmermann C, Swami N, Krzyzanowska M, et al. Early palliative care for
patients with advanced cancer: a cluster-randomised controlled trial. Lancet.
2014;383:1721–30.
9. Maltoni M, Scarpi E, Dall M, et al. Systematic versus on-demand early
palliative care : results from a multicentre , randomised clinical trial. Eur J
Cancer. 2016;65:61–8.
10. Vanbutsele G, Pardon K, Van Belle S, et al. Effect of early and systematic
integration of palliative care in patients with advanced cancer: a
randomised controlled trial. Lancet Oncol. 2018;2045:1–11.
11. Higginson I, Sen-Gupta G. Place of Care in Advanced Cancer: a qualitative
systematic literature review of patient preferences. J Palliat Med. 2000;3:287–
300.
12. Pype P, Symons L, Wens J, et al. Healthcare professionals’ perceptions
toward interprofessional collaboration in palliative home care: a view from
Belgium. J Interprof Care. 2013;27:313–9.
13. Dhollander N, Smets T, De Vleminck A, et al. Phase 0–1 early palliative
home care cancer treatment intervention study. BMJ Support Palliat Care.
2019:1–9.
14. Craig P, Dieppe P, Macintyre S, et al. Developing and evaluating complex
interventions: the new medical research council guidance. Bmj. 2008;337:
979–83.
15. De Sila MJ, Breuer E, Lee L, et al. Theory of change: a theory-driven
approach to enhance the Medical Research Council's framework for
complex interventions. Trials. 2014;15:1–12.
16. Moher D. CONSORT: an evolving tool to help improve the quality of reports
of randomized controlled trials. Consolidated Standards of Reporting Trials.
JAMA. 1998;279:1489-91.
17. Fayers P, Bottomley A. Quality of life research within the EORTC—the
EORTC QLQ-C30. Eur J Cancer. 2002;38:125–33.
18. Spinhoven P, Ormel J, Sloekers PP, et al. A validation study of the hospital
anxiety and depression scale (HADS) in different groups of Dutch subjects.
Psychol Med. 1997:363–70.
19. Vanbutsele G, Van Belle S, De Laat M, et al. The systematic early integration
of palliative care into multidisciplinary oncology care in the hospital setting
(IPAC), a randomized controlled trial: the study protocol. BMC Health Serv
Res. 2015;15:554.
20. Kristjanson LJ. Validity and reliability testing of the Famcare scale: measuring
family satisfaction with advanced Cancer care. Soc Sci Med. 1993;36:693–701.
21. Reyniers T, Houttekier D, Cohen J, et al. The acute hospital setting as a
place of death and final care: a qualitative study on perspectives of family
physicians, nurses and family carers. Heal Place. 2014;27:77–83.
22. Gomes B, Calanzani N, Gysels M, et al. Heterogeneity and changes in
preferences for dying at home: a systematic review. BMC Palliat Care. 2013;12:1.
23. Gomes B, Calanzani N, Curiale V, et al. Effectiveness and cost-effectiveness
of home palliative care services for adults with advanced illness and their
caregivers (Review). Cochrane Database Syst Rev. 6.
24. Taniyama TK, Hashimoto K, Katsumata N, et al. Can oncologists predict
survival for patients with progressive disease after standard
chemotherapies? Curr Oncol. 2014;21:84–90.
25. Cheon S, Agarwal A, Popovic M, et al. The accuracy of clinicians ’ predictions of
survival in advanced cancer: a review. Ann Palliat Med. 2016;5:22–9.
26. Krishnan M, Temel JS, Wright AA, et al. Predicting life expectancy in patients
with advanced incurable cancer : a review. J Support Oncol. 2013;11:68–74.
27. Von Roenn JH, Voltz R, Serrie A. Barriers and Approaches to the Successful
Integration of Palliative Care and Oncology Practice. J Natl Compr Canc
Netw. 2013;11:S11–6.
28. Bakitas M, Lyons KD, Hegel MT, et al. Oncologists’ perspectives on
concurrent palliative care in a National Cancer Institute-designated
comprehensive cancer center. Palliat Support Care. 2013;11:415–23.
29. Ward AM, Agar M, Koczwara B. Collaborating or co-existing: a survey of
attitudes of medical oncologists toward specialist palliative care. Palliat Med.
2009;23:698–707.
30. Kain DA, Eisenhauer EA. Early palliative Care for Patients with advanced
Cancer. Curr Oncol. 2016;23:374–7.
31. Davis MP, Bruera E, Morganstern D. Early integration of palliative and
supportive care in the cancer continuum: challenges and opportunities. Am
Soc Clin Oncol Educ Book. 2013:144–50.
32. Neergaard MA, Olesen F, Jensen AB, et al. Shared Care in Basic Level
Palliative Home Care: organizational and interpersonal challenges. J Palliat
Med. 2010;13:1071–7.
33. Le BHC, Hons M, Mileshkin L, et al. Acceptability of early integration of palliative
Care in Patients with incurable lung Cancer. J Palliat Med. 2014;17:553–8.
34. Temel JS, Greer JA, El-jawahri A, et al. Effects of early integrated palliative
Care in Patients with Lung and GI Cancer: a randomized clinical trial. J Clin
Oncol. 2017;35:834–41.
35. Jacobsen J, Jackson V, Dahlin C, et al. Components of early outpatient
palliative care consultation in patients with metastatic nonsmall cell lung
Cancer. J Palliat Med. 2011;14:459–64.
36. Hannon B, Swami N, Rodin G, et al. Experiences of patients and caregivers
with early palliative care : a qualitative study. Palliat Med. 2017;31:72–81.
37. Hoerger M, Greer JA, Jackson VA, et al. Defining the elements of early
palliative care that are associated with patient-reported outcomes and the
delivery of end-of-life care. J Clin Oncol. 2018;36:1096–102.
38. Dhollander N, Deliens L, Van Belle S, et al. Differences between early and
late involvement of palliative home care in oncology care : a focus group
study with palliative home care teams. Palliat Med. 2018;32(7):1275–82.
39. Gilissen J, Pivodic L, Gastmans C, et al. How to achieve the desired
outcomes of advance care planning in nursing homes: a theory of change.
BMC Geriatr. 2018;18:1–14.
40. Ling S, Chen M, Li C, et al. Trajectory and Influencing Factors of Depressive
Symptoms in Family Caregivers Before and After the Death of Terminally III
Patients With Cancer. Nurs Forum. 2013;40:E32–40.
Dhollander et al. BMC Palliative Care          (2020) 19:174 Page 12 of 13
41. Grov EK, Dahl AA, Moum T, et al. Anxiety, depression, and quality of life in
caregivers of patients with cancer in late palliative phase. Ann Oncol. 2005;
16:1185–91.
42. Kaasa S, Loge JH, Aapro M, et al. Integration of oncology and palliative care:
a Lancet Oncology Commission. Lancet Oncol. 2018;2045:1–66.
43. Hui D, Bansal S, Strasser F, et al. Indicators of integration of oncology and
palliative care programs: An international consensus. Ann Oncol. 2015;26:
1953–59.
44. Hui D, Kim YJ, Park JC, Zhang Y, Strasser F, Cherny N, Kaasa SDMBE.
Integration of Oncology and Palliative Care : A Systematic Review.
Oncologist. 2015;20:77–83.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Dhollander et al. BMC Palliative Care          (2020) 19:174 Page 13 of 13
